Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Losartan Potassium Tablets

Approval Number

H20140913

CompanySandoz Gmbh

Registration Date

April 7, 2020

Previous Approval Numbers

H20140913

Drug Information

Generic Name

氯沙坦钾片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

April 7, 2020

Expiry Date

April 6, 2025

Company Information

Applicant Company

Company NameSandoz Gmbh

Company Address

Biochemiestra β e 10, 6250 Kundl, Austria

Manufacturing Company

Company Name

novartis pharmaceutical manufacturing llc

Company Address

Verovskova ulica 57, Ljubljana, 1000, Slovenia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy